EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deacetyl xylopic acid exhibits synergistic antidepressant-like effects and augments fluoxetine activity in a chronic restraint-induced depression model in mice

Charles Kwaku Benneh, Wonder Kofi Mensah Abotsi, Aliu Moomin, Robert Peter Biney, Japhat Opoku Ofosu, Mustapha Kobina Abeka, Augustine Tandoh, Donatus Wewura Adongo, Eric Woode

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05501-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Charles Kwaku Benneh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, UK. c.benneh@uls…. Hauptthemen laut MEDLINE: Fluoxetine, Antidepressive Agents, Depression. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xylopic acid (XA) and the deacetyl derivative (dXA) have been shown to exhibit antidepressant activity in acute models of depression in mice. This study evaluated and compared the effect of the deacetyl derivative in a chronic restrain model of depression. In the first phase of the study, the synergistic potential of dXA was evaluated using the mouse tail suspension test (TST) and forced swim test (FST). In the second phase, mice were subjected to chronic restraint stress for 42 days, starting from day 0, in ventilated tubes (0800–1400 h). On day 42, stress-naïve and stressed mice were assessed using both the FST and TST to identify the more sensitive behavioural assay for subsequent evaluation of treatment effects. Stressed mice were then administered fluoxetine, XA, dXA, vehicle for 72 h or single acute dosing of combinations of fluoxetine with XA or dXA, followed by repeat behavioural testing 90 min after the last dose of either a single acute or a chronic dosing regimen. The interaction index ( γ ), together with the significantly lower ED 50mix compared to the ED 50add , for the dXA combinations, with fluoxetine, sertraline, imipramine and ketamine is indicative of synergistic effect. An 8-hourly dosing, for 72 h of XA (100 mg kg −1 ) and dXA (100 mg kg −1 ) in the acute models did not reverse the behavioural traits of chronic restrain. However, fluoxetine (30 mg kg −1 ), given 12 hourly for 72 h, and the acute administration of combinations of fluoxetine (100 mg kg −1 ) and dXA (100 mg kg −1 ) significantly reversed the duration of immobility. The present study demonstrates that deacetyl xylopic acid (dXA) exerts synergistic antidepressant—like effects with selective antidepressants and augments the antidepressant effects of fluoxetine in a mouse model of chronic restraint stress-induced depression. These findings suggest that dXA may represent a promising adjunctive agent for improving antidepressant efficacy, particularly in stress-related depressive disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoxetineAntidepressive AgentsDepressionAnimalsMaleDrug SynergismDisease Models, AnimalRestraint, PhysicalMiceBehavior, AnimalStress, PsychologicalDrug Therapy, CombinationSwimming

Stichwörter der Autor:innen

Chronic restrain stressChronic stressIsobolographXylopic acid

Substanzen

FluoxetineAntidepressive Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, UK. c.benneh@ulster.ac.uk.
  • Department of Pharmacology and Toxicology, School of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Rowett Institute, University of Aberdeen, Aberdeen, UK.
  • Department of Pharmacotherapeutics and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of Cape Coast, Cape Coast, Ghana.
  • Department of Pharmaceutical Sciences, Faculty of Applied Science and Technology, Sunyani Technical University, Sunyani, Ghana.
  • Department of Pharmaceutical Chemistry, School of Pharmacy and Pharmaceutical Sciences, University of Cape Coast, Cape Coast, Ghana.

Zitieren

APA

Benneh, C. K., Abotsi, W. K. M., Moomin, A., Biney, R. P., Ofosu, J. O., Abeka, M. K., Tandoh, A., Adongo, D. W., & Woode, E. (2026). Deacetyl xylopic acid exhibits synergistic antidepressant-like effects and augments fluoxetine activity in a chronic restraint-induced depression model in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05501-8

Vancouver

Benneh CK, Abotsi WKM, Moomin A, Biney RP, Ofosu JO, Abeka MK, et al. Deacetyl xylopic acid exhibits synergistic antidepressant-like effects and augments fluoxetine activity in a chronic restraint-induced depression model in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05501-8

BibTeX
@article{Benneh2026,
  author = {Benneh, Charles Kwaku and Abotsi, Wonder Kofi Mensah and Moomin, Aliu and Biney, Robert Peter and Ofosu, Japhat Opoku and Abeka, Mustapha Kobina and Tandoh, Augustine and Adongo, Donatus Wewura and Woode, Eric},
  title = {Deacetyl xylopic acid exhibits synergistic antidepressant-like effects and augments fluoxetine activity in a chronic restraint-induced depression model in mice},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05501-8}
}
Kostenlos starten →